A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system
Benjamin Schrank, Radiation Oncology Resident at
“Thanks go to the best mentors I could ask for Wen Jiang, Betty Y.S. Kim, Albert Koong, Society for Immunotherapy of Cancer and Merck for supporting iADC innovations at MD Anderson Cancer Center.”
Quoting Betty Y.S. Kim‘s post:
“Congrats Benjamin Schrank on the award.
A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system and Tumor agnostic. Thank you, Society for Immunotherapy of Cancer, Merck, Wen Jiang and Albert Koong.“
More post featuring Benjamin Schrank.
Benjamin Schrank is a resident physician at the MD Anderson Cancer Center. Previously, he was a resident physician at the Memorial Sloan Kettering Cancer Center. He earned his MD/PhD from the Columbia University Vagelos College of Physicians and Surgeons.He previously served as a Research Technician at the Massachusetts General Hospital.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023